Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Austin Miller

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 27, 2020
Daily Time of Radiation Treatment Is Associated with Subsequent Oral Mucositis Severity during Radiotherapy in Head and Neck Cancer PatientsFangyi Gu, Mark K Farrugia, William D Duncan, et al.
Leukemia & Lymphoma|January 9, 2010
Efficacy of lenalidomide in patients with chronic lymphocytic leukemia with high-risk cytogeneticsTaimur Sher, Kena C Miller, David Lawrence, et al.
Gynecologic Oncology|March 11, 2023
Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivorsKathryn Osann, Lari Wenzel, Chelsea McKinney, et al.
Gynecologic Oncology|July 7, 2023
A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283Roisin E O'Cearbhaill, Austin Miller, Robert A Soslow, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2020
A Multi-atlas Approach for Active Bone Marrow Sparing Radiation Therapy: Implementation in the NRG-GY006 TrialTahir Yusufaly, Austin Miller, Ana Medina-Palomo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2012
Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patientsKunle Odunsi, Junko Matsuzaki, Julia Karbach, et al.
Cancer Immunology Research|February 19, 2014
Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancerKunle Odunsi, Junko Matsuzaki, Smitha R James, et al.
Gynecologic Oncology|February 27, 2021
Utilizing an interim futility analysis of the OVAL study (VB-111-701/GOG 3018) for potential reduction of risk: A phase III, double blind, randomized controlled trial of ofranergene obadenovec (VB-111) and weekly paclitaxel in patients with platinum resistant ovarian cancerRebecca C Arend, Bradley J Monk, Thomas J Herzog, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2017
A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell CarcinomaAnurag K Singh, Timothy B Winslow, Mohammad Habiby Kermany, et al.
Journal of Endourology|March 15, 2019
Accuracy of American College of Surgeons National Surgical Quality Improvement Program Universal Surgical Risk Calculator in Predicting Complications Following Robot-Assisted Radical Cystectomy at a National Comprehensive Cancer CenterZaeem Lone, Shelby Hall, Tomoaki Terakawa, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 27, 2020
Daily Time of Radiation Treatment Is Associated with Subsequent Oral Mucositis Severity during Radiotherapy in Head and Neck Cancer PatientsFangyi Gu, Mark K Farrugia, William D Duncan, et al.
Leukemia & Lymphoma|January 9, 2010
Efficacy of lenalidomide in patients with chronic lymphocytic leukemia with high-risk cytogeneticsTaimur Sher, Kena C Miller, David Lawrence, et al.
Gynecologic Oncology|March 11, 2023
Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivorsKathryn Osann, Lari Wenzel, Chelsea McKinney, et al.
Gynecologic Oncology|July 7, 2023
A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283Roisin E O'Cearbhaill, Austin Miller, Robert A Soslow, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2020
A Multi-atlas Approach for Active Bone Marrow Sparing Radiation Therapy: Implementation in the NRG-GY006 TrialTahir Yusufaly, Austin Miller, Ana Medina-Palomo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2012
Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patientsKunle Odunsi, Junko Matsuzaki, Julia Karbach, et al.
Cancer Immunology Research|February 19, 2014
Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancerKunle Odunsi, Junko Matsuzaki, Smitha R James, et al.
Gynecologic Oncology|February 27, 2021
Utilizing an interim futility analysis of the OVAL study (VB-111-701/GOG 3018) for potential reduction of risk: A phase III, double blind, randomized controlled trial of ofranergene obadenovec (VB-111) and weekly paclitaxel in patients with platinum resistant ovarian cancerRebecca C Arend, Bradley J Monk, Thomas J Herzog, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2017
A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell CarcinomaAnurag K Singh, Timothy B Winslow, Mohammad Habiby Kermany, et al.
Journal of Endourology|March 15, 2019
Accuracy of American College of Surgeons National Surgical Quality Improvement Program Universal Surgical Risk Calculator in Predicting Complications Following Robot-Assisted Radical Cystectomy at a National Comprehensive Cancer CenterZaeem Lone, Shelby Hall, Tomoaki Terakawa, et al.
Pageof 14